Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa
AssigneeThe Brigham and Women's Hospital, Inc.
InventorGerald B. Pier
Life of this patent
Estimating the term…
Abstract
A method of inducing an immune response against multiple strains of Pseudomonas aeruginosa which comprises administering to a human or animal an amount of mucoid exopolysaccharide from Pseudomonas aeruginosa 2192 sufficient to induce an immune response in the human or animal is disclosed along with the microorganism which produces this antigen and a method of separating the antigen from the crude bacterial slime.
Claims3
A bacterial antigen comprising isolated mucoid exopolysaccharide comprising a polymer uronic acid formed principally from mannuronic and guluronic acids having the antigenic characteristics of Pseudomonas aeruginosa 2192.
Dependencies are inferred from the claim text.